Epicardial perivascular adipose tissue as a therapeutic target in obesity-related coronary artery disease

Gregory A. Payne, Meredith C. Kohr, Johnathan D. Tune

Research output: Contribution to journalReview article

69 Citations (Scopus)

Abstract

Adipose tissue is an active endocrine and paracrine organ that may influence the development of atherosclerosis and vascular disease. In the setting of obesity, adipose tissue produces a variety of inflammatory cytokines (or adipokines) that are known to modulate key mechanisms of atherogenesis. In particular, adipose tissue located on the surface of the heart surrounding large coronary arteries (i.e. epicardial perivascular adipose tissue) has been implicated in the pathogenesis of coronary artery disease. The present review outlines our current understanding of the cellular and molecular links between perivascular adipose tissue and atherosclerosis with a focus on potential mechanisms by which epicardial perivascular adipose tissue contributes to obesity-related coronary disease. The pathophysiology of perivascular adipose tissue in obesity and its influence on oxidative stress, inflammation, endothelial dysfunction and vascular reactivity is addressed. In addition, the contribution of specific epicardial perivascular adipose-derived adipokines (e.g. leptin, adiponectin) to the initiation and expansion of coronary disease is also highlighted. Finally, future investigative goals are discussed with an emphasis on indentifying novel therapeutic targets and disease markers within perivascular adipose tissue. Linked Articles This article is part of a themed section on Fat and Vascular Responsiveness. To view the other articles in this section visit

Original languageEnglish (US)
Pages (from-to)659-669
Number of pages11
JournalBritish Journal of Pharmacology
Volume165
Issue number3
DOIs
StatePublished - Feb 1 2012

Fingerprint

Adipose Tissue
Coronary Artery Disease
Obesity
Atherosclerosis
Adipokines
Therapeutics
Coronary Disease
Blood Vessels
Adiponectin
Leptin
Vascular Diseases
Coronary Vessels
Oxidative Stress
Fats
Cytokines
Inflammation

Keywords

  • adipokines
  • adiponectin
  • coronary artery disease
  • coronary circulation
  • endothelial dysfunction
  • epicardial adipose tissue
  • inflammation
  • leptin
  • obesity
  • perivascular adipose tissue

ASJC Scopus subject areas

  • Pharmacology

Cite this

Epicardial perivascular adipose tissue as a therapeutic target in obesity-related coronary artery disease. / Payne, Gregory A.; Kohr, Meredith C.; Tune, Johnathan D.

In: British Journal of Pharmacology, Vol. 165, No. 3, 01.02.2012, p. 659-669.

Research output: Contribution to journalReview article

@article{9d711117458f48258902bb194769146b,
title = "Epicardial perivascular adipose tissue as a therapeutic target in obesity-related coronary artery disease",
abstract = "Adipose tissue is an active endocrine and paracrine organ that may influence the development of atherosclerosis and vascular disease. In the setting of obesity, adipose tissue produces a variety of inflammatory cytokines (or adipokines) that are known to modulate key mechanisms of atherogenesis. In particular, adipose tissue located on the surface of the heart surrounding large coronary arteries (i.e. epicardial perivascular adipose tissue) has been implicated in the pathogenesis of coronary artery disease. The present review outlines our current understanding of the cellular and molecular links between perivascular adipose tissue and atherosclerosis with a focus on potential mechanisms by which epicardial perivascular adipose tissue contributes to obesity-related coronary disease. The pathophysiology of perivascular adipose tissue in obesity and its influence on oxidative stress, inflammation, endothelial dysfunction and vascular reactivity is addressed. In addition, the contribution of specific epicardial perivascular adipose-derived adipokines (e.g. leptin, adiponectin) to the initiation and expansion of coronary disease is also highlighted. Finally, future investigative goals are discussed with an emphasis on indentifying novel therapeutic targets and disease markers within perivascular adipose tissue. Linked Articles This article is part of a themed section on Fat and Vascular Responsiveness. To view the other articles in this section visit",
keywords = "adipokines, adiponectin, coronary artery disease, coronary circulation, endothelial dysfunction, epicardial adipose tissue, inflammation, leptin, obesity, perivascular adipose tissue",
author = "Payne, {Gregory A.} and Kohr, {Meredith C.} and Tune, {Johnathan D.}",
year = "2012",
month = "2",
day = "1",
doi = "10.1111/j.1476-5381.2011.01370.x",
language = "English (US)",
volume = "165",
pages = "659--669",
journal = "British Journal of Pharmacology",
issn = "0007-1188",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Epicardial perivascular adipose tissue as a therapeutic target in obesity-related coronary artery disease

AU - Payne, Gregory A.

AU - Kohr, Meredith C.

AU - Tune, Johnathan D.

PY - 2012/2/1

Y1 - 2012/2/1

N2 - Adipose tissue is an active endocrine and paracrine organ that may influence the development of atherosclerosis and vascular disease. In the setting of obesity, adipose tissue produces a variety of inflammatory cytokines (or adipokines) that are known to modulate key mechanisms of atherogenesis. In particular, adipose tissue located on the surface of the heart surrounding large coronary arteries (i.e. epicardial perivascular adipose tissue) has been implicated in the pathogenesis of coronary artery disease. The present review outlines our current understanding of the cellular and molecular links between perivascular adipose tissue and atherosclerosis with a focus on potential mechanisms by which epicardial perivascular adipose tissue contributes to obesity-related coronary disease. The pathophysiology of perivascular adipose tissue in obesity and its influence on oxidative stress, inflammation, endothelial dysfunction and vascular reactivity is addressed. In addition, the contribution of specific epicardial perivascular adipose-derived adipokines (e.g. leptin, adiponectin) to the initiation and expansion of coronary disease is also highlighted. Finally, future investigative goals are discussed with an emphasis on indentifying novel therapeutic targets and disease markers within perivascular adipose tissue. Linked Articles This article is part of a themed section on Fat and Vascular Responsiveness. To view the other articles in this section visit

AB - Adipose tissue is an active endocrine and paracrine organ that may influence the development of atherosclerosis and vascular disease. In the setting of obesity, adipose tissue produces a variety of inflammatory cytokines (or adipokines) that are known to modulate key mechanisms of atherogenesis. In particular, adipose tissue located on the surface of the heart surrounding large coronary arteries (i.e. epicardial perivascular adipose tissue) has been implicated in the pathogenesis of coronary artery disease. The present review outlines our current understanding of the cellular and molecular links between perivascular adipose tissue and atherosclerosis with a focus on potential mechanisms by which epicardial perivascular adipose tissue contributes to obesity-related coronary disease. The pathophysiology of perivascular adipose tissue in obesity and its influence on oxidative stress, inflammation, endothelial dysfunction and vascular reactivity is addressed. In addition, the contribution of specific epicardial perivascular adipose-derived adipokines (e.g. leptin, adiponectin) to the initiation and expansion of coronary disease is also highlighted. Finally, future investigative goals are discussed with an emphasis on indentifying novel therapeutic targets and disease markers within perivascular adipose tissue. Linked Articles This article is part of a themed section on Fat and Vascular Responsiveness. To view the other articles in this section visit

KW - adipokines

KW - adiponectin

KW - coronary artery disease

KW - coronary circulation

KW - endothelial dysfunction

KW - epicardial adipose tissue

KW - inflammation

KW - leptin

KW - obesity

KW - perivascular adipose tissue

UR - http://www.scopus.com/inward/record.url?scp=84855682678&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855682678&partnerID=8YFLogxK

U2 - 10.1111/j.1476-5381.2011.01370.x

DO - 10.1111/j.1476-5381.2011.01370.x

M3 - Review article

C2 - 21545577

AN - SCOPUS:84855682678

VL - 165

SP - 659

EP - 669

JO - British Journal of Pharmacology

JF - British Journal of Pharmacology

SN - 0007-1188

IS - 3

ER -